Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis.


Abstract

Liver fibrosis was an independent moderator of treatment outcome in patients receiving PegIFNα2b, not in those receiving PegIFNα2a.


Full Text


Subjects


Similar articles

Authors


Publication date

2012-01-18


Journal

Journal of hepatology
J Hepatol (0168-8278)



Journal topics


Language

Eng.


Copyright

Journal of Hepatology

A.M. Migliavacca Center for Liver Disease, 1st Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy.


Release reference

J Hepatol. 2012 Feb;56(2):341-7



Related books


Español | English

© Galenicom 1999-2013